F
Fennec Pharmaceuticals Inc.
FENC · NASDAQ · Healthcare · 407M
Price · close
$11.29
-0.53% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
9.2×
Enterprise value / EBITDAEV/EBITDA
-38.4×
Free cash flow yieldFCF yield
-3.9%
Return on equityROE
-27.8%
Operating margin
-14.2%
Net debt / EBITDAbalance-sheet strength
4.9×
Interest coverage
-3.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.